Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C25H31F3O5S |
Molecular Weight | 500.571 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]3(F)[C@@]2([H])C[C@H](F)C4=CC(=O)C=C[C@]34C
InChI
InChIKey=WMWTYOKRWGGJOA-CENSZEJFSA-N
InChI=1S/C25H31F3O5S/c1-5-20(31)33-25(21(32)34-12-26)13(2)8-15-16-10-18(27)17-9-14(29)6-7-22(17,3)24(16,28)19(30)11-23(15,25)4/h6-7,9,13,15-16,18-19,30H,5,8,10-12H2,1-4H3/t13-,15+,16+,18+,19+,22+,23+,24+,25+/m1/s1
Molecular Formula | C25H31F3O5S |
Molecular Weight | 500.571 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:13:48 UTC 2023
by
admin
on
Fri Dec 15 15:13:48 UTC 2023
|
Record UNII |
O2GMZ0LF5W
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
273208
Created by
admin on Fri Dec 15 15:13:48 UTC 2023 , Edited by admin on Fri Dec 15 15:13:48 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/16/1815
Created by
admin on Fri Dec 15 15:13:48 UTC 2023 , Edited by admin on Fri Dec 15 15:13:48 UTC 2023
|
||
|
FDA ORPHAN DRUG |
319410
Created by
admin on Fri Dec 15 15:13:48 UTC 2023 , Edited by admin on Fri Dec 15 15:13:48 UTC 2023
|
||
|
FDA ORPHAN DRUG |
499815
Created by
admin on Fri Dec 15 15:13:48 UTC 2023 , Edited by admin on Fri Dec 15 15:13:48 UTC 2023
|
||
|
NCI_THESAURUS |
C521
Created by
admin on Fri Dec 15 15:13:48 UTC 2023 , Edited by admin on Fri Dec 15 15:13:48 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
444036
Created by
admin on Fri Dec 15 15:13:48 UTC 2023 , Edited by admin on Fri Dec 15 15:13:48 UTC 2023
|
PRIMARY | |||
|
SUB02241MIG
Created by
admin on Fri Dec 15 15:13:48 UTC 2023 , Edited by admin on Fri Dec 15 15:13:48 UTC 2023
|
PRIMARY | |||
|
m5510
Created by
admin on Fri Dec 15 15:13:48 UTC 2023 , Edited by admin on Fri Dec 15 15:13:48 UTC 2023
|
PRIMARY | Merck Index | ||
|
FLUTICASONE PROPIONATE
Created by
admin on Fri Dec 15 15:13:48 UTC 2023 , Edited by admin on Fri Dec 15 15:13:48 UTC 2023
|
PRIMARY | |||
|
CHEMBL1473
Created by
admin on Fri Dec 15 15:13:48 UTC 2023 , Edited by admin on Fri Dec 15 15:13:48 UTC 2023
|
PRIMARY | |||
|
O2GMZ0LF5W
Created by
admin on Fri Dec 15 15:13:48 UTC 2023 , Edited by admin on Fri Dec 15 15:13:48 UTC 2023
|
PRIMARY | |||
|
100000092718
Created by
admin on Fri Dec 15 15:13:48 UTC 2023 , Edited by admin on Fri Dec 15 15:13:48 UTC 2023
|
PRIMARY | |||
|
1225
Created by
admin on Fri Dec 15 15:13:48 UTC 2023 , Edited by admin on Fri Dec 15 15:13:48 UTC 2023
|
PRIMARY | |||
|
759889
Created by
admin on Fri Dec 15 15:13:48 UTC 2023 , Edited by admin on Fri Dec 15 15:13:48 UTC 2023
|
PRIMARY | |||
|
O2GMZ0LF5W
Created by
admin on Fri Dec 15 15:13:48 UTC 2023 , Edited by admin on Fri Dec 15 15:13:48 UTC 2023
|
PRIMARY | |||
|
DB00588
Created by
admin on Fri Dec 15 15:13:48 UTC 2023 , Edited by admin on Fri Dec 15 15:13:48 UTC 2023
|
PRIMARY | |||
|
W-145
Created by
admin on Fri Dec 15 15:13:48 UTC 2023 , Edited by admin on Fri Dec 15 15:13:48 UTC 2023
|
PRIMARY | |||
|
80474-14-2
Created by
admin on Fri Dec 15 15:13:48 UTC 2023 , Edited by admin on Fri Dec 15 15:13:48 UTC 2023
|
PRIMARY | |||
|
1285873
Created by
admin on Fri Dec 15 15:13:48 UTC 2023 , Edited by admin on Fri Dec 15 15:13:48 UTC 2023
|
PRIMARY | |||
|
50121
Created by
admin on Fri Dec 15 15:13:48 UTC 2023 , Edited by admin on Fri Dec 15 15:13:48 UTC 2023
|
PRIMARY | RxNorm | ||
|
7080
Created by
admin on Fri Dec 15 15:13:48 UTC 2023 , Edited by admin on Fri Dec 15 15:13:48 UTC 2023
|
PRIMARY | |||
|
C29061
Created by
admin on Fri Dec 15 15:13:48 UTC 2023 , Edited by admin on Fri Dec 15 15:13:48 UTC 2023
|
PRIMARY | |||
|
DTXSID8045511
Created by
admin on Fri Dec 15 15:13:48 UTC 2023 , Edited by admin on Fri Dec 15 15:13:48 UTC 2023
|
PRIMARY | |||
|
31441
Created by
admin on Fri Dec 15 15:13:48 UTC 2023 , Edited by admin on Fri Dec 15 15:13:48 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
EP
|
||
|
PARENT -> DERIVATIVE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
PROTEIN BINDING (PLASMA PROTEIN) | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
TOPICAL PHARMACOKINETIC |
|
||
MAXIMUM TOLERATED DOSE | TOXICITY |
|
FLOVENT HFA INHALATION AEROSOL |
|
||
ORAL BIOAVAILABILITY | PHARMACOKINETIC |
|
INHALATION, AEROSOL: ALMOST COMPLETE PHARMACOKINETIC |
|
||
Route of Elimination | PHARMACOKINETIC |
|
RENAL PHARMACOKINETIC |
|
||